Limits of Patentability

Plant Sciences, Stem Cells and Nucleic Acids

  • Andreas Hübel
  • Ulrich Storz
  • Aloys Hüttermann

Part of the SpringerBriefs in Biotech Patents book series (BRIEFSBIOTECH)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Ulrich Storz
    Pages 9-32
  3. Back Matter
    Pages 45-46

About this book

Introduction

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. In this volume the limits of patentability are addressed, a question that is often raised when it comes to biotechnological inventions: The first section addresses current issues in the patentability of plants produced by essentially biological processes including the controversy between farmer’s privilege and patent exhaustion with respect to seeds in the US. The second section examines the patentability of human embryonic stem cells in Europe and the US, also considering alternative technologies with respect to their practicability and patentability. The third section focuses on the patentability of genes and nucleic acids, especially the issue of patenting of encoding genes and nucleic acids.

Keywords

Biopatent law Intellectual property Patentability of genes Plant breeding patents Product-by-process claims Stem cells

Authors and affiliations

  • Andreas Hübel
    • 1
  • Ulrich Storz
    • 2
  • Aloys Hüttermann
    • 3
  1. 1.Patent AttorneysMichalski Huettermann & PartnerDuesseldorfGermany
  2. 2.Patent AttorneysMichalski Huettermann & PartnerDuesseldorfGermany
  3. 3.Michalski Huettermann & PartnerDuesseldorfGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-32841-1
  • Copyright Information The Author(s) 2013
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-642-32840-4
  • Online ISBN 978-3-642-32841-1
  • Series Print ISSN 2192-9904
  • Series Online ISSN 2192-9912
  • About this book
Industry Sectors
Biotechnology
Pharma